Ampio Pharmaceuticals Inc AMPE

ASE: AMPE | ISIN: US03209T1097 14/11/2024

0,002 USD (0,00%)

(0,00%) 14/11/2024

Grafiek Ampio Pharmaceuticals Inc

Grafiek Ampio Pharmaceuticals Inc

1 dag1d 0,00%
1 week1w 120,00%
1 maand1m 0,00%
3 maanden3m 46,67%
6 maanden6m -99,00%
1 jaar1j -99,92%
5 jaar5j -99,45%

Ampio Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

2 juni 2022 · Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders · Persbericht

16 mei 2022 · Ampio Pharmaceuticals Reports First-Quarter Financial Results · Persbericht

16 mei 2022 · Ampio Independent Committee to Conduct Investigation · Persbericht

27 april 2022 · Ampio Pharmaceuticals, Inc. to Hold Conference Call · Persbericht

20 april 2022 · Ampio Provides Regulatory Update · Persbericht

29 maart 2022 · Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights · Persbericht

23 maart 2022 · Ampio Pharmaceuticals, Inc. to Hold Fourth Quarter 2021 Earnings and Business Update Call · Persbericht

9 maart 2022 · Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference · Persbericht

2 maart 2022 · Ampio Pharmaceuticals, Inc. Releases Positive Phase 3 Data Analysis for Ampion™ Targeting Severe Osteoarthritis of the Knee (OAK) · Persbericht

2 maart 2022 · Ampio Pharmaceuticals, Inc. to Host a Conference Call and Webinar · Persbericht

Profiel Ampio Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: ampiopharma.com

Hoofdzetel: Englewood, Colorado Verenigde Staten

CEO: Michael Macaluso

Werknemers: 19

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe